In cohort 2, 100 FFPE tumour specimens from CRC patients previously analyzed by ME-PCR and DS were retrospectively tested by the SensiScreen® FFPE BRAF qPCR simplex Assay. Here, BRAF is linked to colorectal carcinoma.